1. Early disease course is unaltered in mucopolysaccharidosis type IIIA (MPS IIIA) mice lacking α‐synuclein. (25th April 2019) Authors: Soe, K.; Beard, H.; Neumann, D.; Trim, P. J.; Duplock, S.; Snel, M. F.; Hopwood, J. J.; Hemsley, K. M. Journal: Neuropathology & applied neurobiology Issue: Volume 45:Number 7(2019) Page Start: 715 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0060 The Relationship between Adherence To A Treat-To-Target Approach for Clinical Care of US Patients with Rheumatoid Arthritis and Achievement of Low Disease Activity. (15th July 2016) Authors: Harrold, L.R.; Reed, G.W.; John, A.; Barr, C.J.; Saunders, K.C.; Soe, K.; Magner, R.; Greenberg, J.D.; Kremer, J.M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗